Is There a Better Screening Tool for Cognitive Function and Employment Status in Patients With MS?May 27, 2015Multiple Sclerosis
Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1aMay 26, 2015Multiple Sclerosis
